Revealed — how junk food 'controls' you!

Revealed — how junk food 'controls' you!
The researchers believe that a junk diet causes lasting changes in the reward circuit parts of the rats' brain, for example, the orbitofrontal cortex, an area of the brain responsible for decision-making. They said these results may have implications …
Read more on TheHealthSite

One in four with enlarged prostates suffer anxiety and depression, says new study
An enlarged prostate causes urinary problems and may lead to kidney failure in the worst cases. Many men with the condition often wake up … Those with enlarged prostates may also experience erectile dysfunction. In North America, one in three men …
Read more on The Straits Times

Eye changes can predict dementia
dementia A loss of cells in the retina is one of the earliest signs of a form of dementia in people with a genetic risk for the brain disorder – even before any changes appear in their behaviour, says a study. The US Researchers discovered that before …
Read more on TheHealthSite

As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics

New York, New York (PRWEB) July 29, 2014

As testosterone treatment lawsuits ( continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a new study is questioning the effectiveness of these medications in men with Type 2 diabetes. The research, which was published online by The Journal of Clinical Endocrinology & Metabolism on June 30th, involved 88 men who suffered from Type 2 diabetes, all of whom had mild to moderate aging male symptoms and erectile dysfunction. Roughly half of the study subjects were treated with a testosterone injection for 40 weeks, while the remainder received a placebo. Self-administered questionnaires were used at 0, 18 and 40 weeks to measure general health and sexual symptoms.*

During the study, no substantial improvements were seen in the men undergoing low testosterone treatment compared to those who received a placebo. The authors of the article concluded that their findings do not support the use of testosterone therapy to improve general health or sexual symptoms in men who suffer from Type 2 diabetes.

Dozens of testosterone lawsuits currently pending in courts around the country allege that the serious cardiovascular risks associated with low testosterone therapy do not outweigh their benefits. This study would seem to substantiate those claims for this particular patient population, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating testosterone lawsuits on behalf of men who were allegedly suffered heart attacks, strokes, blood clots and other serious cardiovascular problems due to their use of low testosterone therapies.

Testosterone Lawsuits

The safety and effectiveness of testosterone replacement therapy has been under scrutiny since this past January, when the U.S. Food & Drug Administration (FDA) announced it was investigating the cardiovascular side effects associates with this class of medications. The review was prompted by two studies which indicated that older men, as well as those with pre-existing heart disease, were more likely to suffer heart attacks, strokes or death if they were using testosterone medications.

According to a notice posted on the FDAs website, the agency will convene a joint meeting of the Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on September 17, 2014, at which time the members will be asked to make recommendations pertaining to the cardiovascular side effects associated with the medications. The Committees will also address what factors should be considered when deciding whether men need to use low testosterone therapy.*

Since the FDA announced its testosterone safety review, court documents indicate that more than 150 testosterone treatment lawsuits have been filed in U.S. courts. The majority of these claims are pending in the U.S. District Court, Northern District of Illinois, where all federally-filed testosterone lawsuits have been consolidated for coordinated pretrial proceedings. Among other things, plaintiffs in these cases allege that the manufacturers of low testosterone therapies failed to provide doctors and patients with adequate warnings regarding their serious cardiovascular side effects. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other serious cardiovascular problems due to low testosterone therapy may be entitled to file their own testosterone lawsuit. To learn more, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*, JECM, June 30, 2014

**, FDA, July 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016



After Other Company Abruptly Closes Mens Health Clinic in Omaha, NuMale Medical Center Emphasizes Importance of Working with Qualified, Professional Medical Centers

Omaha, NE (PRWEB) July 17, 2014

After the sudden closing of a mens clinic in Omaha that shocked patients and employees,* NuMale Medical Center is stressing the importance of consulting qualified, medical professionals at reputable treatment facilities.

A well-established, nationwide clinic for mens sexual health run by accomplished physicians, NuMale Medical Center launched its fifth specialty facility in Omaha last week. The company today is assuring current patients and interested consumers in Nebraska that it is here to stay. NuMales Omaha staff looks forward to providing area residents with customized, comprehensive programs for treating male sexual dysfunction and enhancing their health.

In addition to the new Omaha mens clinic, NuMale runs successful health clinics in Milwaukee, WI, Austin, TX, Chicago, IL, and Las Vegas, NV. NuMale expects to open a number of other offices within the coming year.

About NuMale Medical Center

NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation (PE) and low sex drive, utilizing a wide range of the most highly-respected, FDA-approved treatments and therapies including bio-identical hormone replacement and the Priapus shot. Founded and led by accomplished physician Dr. Christopher Asandra, NuMale Medical Center currently runs five nationwide facilities with many more to come. Learn more at and follow the company on Facebook, Twitter and LinkedIn.

*Sudden Clinic Closing Shocks Patients & Employees, 7.16.14,–Employees-267438961.html

Small Study Reveals that Cancer Drug Reverses Baldness

Small Study Reveals that Cancer Drug Reverses Baldness
A small study whose findings have been made public, revealed that a drug that was used to treat a unusual form of leukemia had the peculiar side effect of reversing hair loss caused by alopecia. The study was published on Sunday, in the Nature Medicine …
Read more on The Utah People’s Post

Proposed FDA Ban on All OTC Teething Meds Opens Doors for Guaranteed
Sanford, FL, August 22, 2014 –(– A consumer advocacy group has urged the FDA to ban all OTC teething medications that contain a topical anesthetic known as benzocaine, which causes adverse reactions in infants and toddlers. The proponents …
Read more on (press release)

OMS preocupada com morte de 120 profissionais de saúde por ébola
Or stick around and fight a bulk dysfunction. cialis 40 mg preis Erectile blades included parasol-bearers, a long experienced debts, and a rare little dysfunctions. A perda de médicos e enfermeiros tornou difícil o apoio em pessoal médico estrangeiro …
Read more on África 21 Digital